Bibliography VSI 2013 Summer Newsletter

Anbar TS, Abdel-Raouf H, Awad SS, Ragaie MH, Abdel-Rahman AT. (2009) The hair follicle melanocytes in vitiligo in relation to disease duration. Journal of the European Academy of Dermatology and Venereology. 23:934-939. doi: 10.1111/j.1468-3083.2009.03233.x.

Bakis-Petsoglou S, Le Guay JL, Wittal R. (2009) A randomized, double-blind, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo. British Journal of Dermatology. Oct;161(4): 910-7. doi: 10:1111/j.1365-2133.2009.09252.x. Epub 2009 Jun 11.

Clinuvel. (2012) Observations from Clinuvel’s US vitiligo study published. Clinuvel press release. http://www.clinuvel.com/en/vitiligo.

Gawkrodger DJ. (2009) Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture. British Journal of Dermatology. 161:721-722.

Gey A, Diallo A, Seneschal J, Leaute-Labreze C, Boralevi F, Jouary T, Taieb A, Ezzedine K. (2013) Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. 168: 756-761.

Grimes PE, Hamzavi H, Lebwohl M, Ortonne JP, Lim HW. (2013) The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. Journal of American Medical Association. 149(1):68-73.

Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi R. (2012) Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. 28:115-119.

Kroon MW, Vrijman C, Chandeck C, Wind BS, Wolkerstorfer A, Luiten RM, Bos JD, Geskus RB, van Trotsenburg ASP, Wietze van der Veen JP. (2013) High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Hormone Research in Pediatrics. 79:137-144.

Laddha NC, Dwivedi M,  Mohmmad S, Gani AR, Md A, Ramachandran AV, Dalai S, Begum R. (2013) Vitiligo: interplay between oxidative stress and immune system. Experimental Dermatology. 22:245-250. Doi: 10.1111/exd.12103.

Maresca V, Flori E, Briganti S, Mastrofrancesco A, Fabbri C, Mileo A, Paggi M, Picardo M. (2007) Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress. Pigment Cell Melanoma Research. 21:200-205.

Martin N, Gagn C, Bergeron J, Jobin J, Poirier P. (2004) Positive pleitropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids in Health and Disease. 3:7.

Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, Kumar P, Denman CJ, Lacek AT, Kohlhapp FJ, Alamiri A, Hughes T, Bines SD, Kaufman HL, Overbeck A, Mehrotra S, Hernandez C, Nishimura MI, Guevara-Patino JA, Le Poole IC. (2013) Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Science Translational Medicine. 5(174): 174ra28. Doi: 10.1126/scitranslmed.3005127.

Park JH, Park SW, Lee DY, Lee JH, Yang JM. (2013) The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. 29:103-105.

Passeron T, Ortonne JP. (2012) Activation of the unfolded protein response in vitiligo: the missing link. Journal of Investigative Dermatology. 132: 2502-2504.

Schallreuter KU, Moore J, Wood JM, Beazley WD, Gaze DC, Tobin DJ, Marshall HS, Panske A, Panzig E, Hibberts NA. (1999) In vivo and in vitro evidence for hydrogen peroxide (H202) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. Sep;4(1):91-6.

Schallreuter KU, Mohammed AELS, Holtz S, Panske A. (2013) Basic evidence for epidermal H2O2/ONOO---mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS. The FASEB Journal. fj.12-226779. Published online April 29, 2013.

Singh S, Singh U, Pandey SS. (2012) Serum concentration of IL-6, IL-2, TNF-α, and IFNy in vitiligo patients. Indian Journal of Dermatology. 57(1):12-4. Doi: 10.4103/0019-5154.92668.

Spritz, Richard A. (2010) The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Medicine 2010, 2:78 doi:10.1186/gm199. http://genomemedicine.com/content/2/10/78.

Van Geel N,  Speeckaert M, Brochez L, Lambert J, Speeckaert R. (2013) Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases. Doi. 10.1111/jdv.12169.

Vitiligo Research Foundation. http://vrfoundation.org/research-page/publications/sodium-oxodihydroacridinylacetate.